Medicine for treating leucocytopenia caused after tumor radiotherapy and chemotherapy

A leukopenia and drug technology, applied in the field of medicine, can solve the problems of patients with greater physical damage, inability to improve symptoms, and affecting treatment effects.

Inactive Publication Date: 2006-12-27
刘文华
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, most of the treatment methods for tumors are combined with radiotherapy and chemical therapy in combination with drug therapy or surgical treatment. Chemotherapy has a lot of toxic and side effects, which will cause leukopenia and cause great damage to the patient's body. For this reason, injections to increase white blood cells are also used. This method can only increase white blood cells, but many symptoms of patients cannot be improved, which greatly affects the therapeutic effect. It also reduces the patient's immune function and quality of life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Take 20kg astragalus, 25kg medlar, 10kg American ginseng, 15kg angelica, 15kg Ligustrum lucidum, 25kg black lotus, 15kg fried Atractylodes macrocephala, 25kg ganoderma, 5kg ganoderma, 25kg dodder, 5kg psoralen, 25kg scrophulariaceae and 5kg orange peel. The above-mentioned traditional Chinese medicine raw materials are decocted in water according to a conventional method, and the decoction is concentrated, dried and powdered, and then packed into capsules to form the medicine of the present invention.

Embodiment 2

[0100] Take 25kg of astragalus, 20kg of medlar, 12kg of American ginseng, 10kg of angelica, 20kg of Ligustrum lucidum, 20kg of Eclipta, 20kg of fried Atractylodes macrocephala, 20kg of Chinese yam, 10kg of Ganoderma lucidum, 20kg of dodder, 10kg of psoraleae, 20kg of scrophulariaceae and 10kg of tangerine peel. The above-mentioned traditional Chinese medicine raw materials are decocted in water according to a conventional method, and the decoction is concentrated, dried and powdered, and then packed into capsules to form the medicine of the present invention.

Embodiment 3

[0102] Take 30kg of astragalus, 15kg of medlar, 15kg of American ginseng, 5kg of angelica, 25kg of Ligustrum lucidum, 15kg of Eclipta chinensis, 25kg of fried Atractylodes macrocephala, 15kg of Chinese yam, 15kg of Ganoderma lucidum, 15kg of dodder seed, 15kg of psoralen, 15kg of scrophulariaceae and 15kg of tangerine peel, The above-mentioned traditional Chinese medicine raw materials are decocted in water according to a conventional method, and the decoction is concentrated, dried and powdered, and then packed into capsules to form the medicine of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating leucopenia after chemotherapy, wherein the active constituents are prepared from the following Chinese medicinal materials (by weight proportion): astragalus root 20-30 parts, wolfberry fruit 15-25 parts, American ginseng 10-15 parts, Chinese angelica root 5-15 parts, ligustrum japonicum 15-25 parts, herba ecliptae 15-25 parts, white atractylodes rhizome 15-25 parts, Chinese yam 15-25 parts, ganoderma lucidum 5-15 parts, doddor seed 15-25 parts, psoralea fruit 5-15 parts, scrophularia root 15-25 parts and dried orange peel 5-15 parts.

Description

technical field [0001] The invention relates to a medicine for treating leukopenia after tumor radiotherapy and chemotherapy, which belongs to the field of medicine. Background technique [0002] Leukocytes are reduced after tumor radiotherapy and chemotherapy. The pathogenesis is mainly due to cytotoxic drugs or radiation directly inhibiting bone marrow hematopoietic cells, or destroying cellular nucleic acid metabolism and hindering cell division. The severity of the disease is related to the severity of drugs or radiation. The clinical manifestations of leukopenia are related to the degree of leukopenia. A small number of patients are asymptomatic, and most patients have symptoms such as dizziness, fatigue, shortness of breath, and poor appetite. This disease belongs to the category of "consumption" and "vertigo" in traditional Chinese medicine. Since the tumor is caused by the combination of toxic heat, blood stasis, and turbid phlegm, "where the evil gathers, its qi mus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61K9/48A61P7/00A61P35/00
Inventor 刘文华
Owner 刘文华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap